Form 8-K - Current report:
SEC Accession No. 0001564590-20-054793
Filing Date
2020-11-20
Accepted
2020-11-20 16:18:09
Documents
2
Period of Report
2020-11-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvus-8k_20201120.htm 8-K 38185
2 EX-3.1 nvus-ex31_6.htm EX-3.1 222906
  Complete submission text file 0001564590-20-054793.txt   262356
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 201332740
SIC: 2834 Pharmaceutical Preparations